ankylosing spondylitis

golf in hole
Biotech

Akeso scores twice in phase 3, tees up regulatory submission

Akeso is adding a pair of late-stage wins to its scorecard in both ankylosing spondylitis and atopic dermatitis.
Gabrielle Masson Aug 25, 2025 1:37pm
On target clinical trial success bullseye score

Lynk hits main goal to wrap up clean sweep of phase 2 JAK trials

Aug 23, 2023 9:55am